1. FcγR interaction is not required for effective anti‐PD‐L1 immunotherapy but can add additional benefit depending on the tumor model. Issue 2 (12th November 2018) Authors: Sow, Heng Sheng; Benonisson, Hreinn; Breukel, Cor; Visser, Remco; Verhagen, Onno J.H.M.; Bentlage, Arthur E.H.; Brouwers, Conny; Claassens, Jill W.C.; Linssen, Margot M.; Camps, Marcel; van Hall, Thorbald; Ossendorp, Ferry; Fransen, Marieke F.; Vidarsson, Gestur; Verbeek, J. Sjef Journal: International journal of cancer Issue: Volume 144:Issue 2(2019) Page Start: 345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗